Russell George Vasile, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Phobic Disorders | 7 | 2005 | 441 | 0.330 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 6 | 1997 | 1141 | 0.250 |
Why?
|
| Panic Disorder | 8 | 2003 | 613 | 0.240 |
Why?
|
| Benzodiazepines | 3 | 2008 | 1139 | 0.240 |
Why?
|
| Depressive Disorder | 12 | 1998 | 3726 | 0.220 |
Why?
|
| Seasonal Affective Disorder | 3 | 1997 | 49 | 0.210 |
Why?
|
| Anxiety Disorders | 7 | 2008 | 2748 | 0.190 |
Why?
|
| Drug Utilization | 3 | 2008 | 1191 | 0.180 |
Why?
|
| Evoked Potentials, Visual | 2 | 1992 | 420 | 0.150 |
Why?
|
| Phototherapy | 2 | 1997 | 368 | 0.140 |
Why?
|
| Technetium Compounds | 1 | 1996 | 15 | 0.140 |
Why?
|
| Agoraphobia | 5 | 2003 | 177 | 0.130 |
Why?
|
| Personality Disorders | 2 | 1994 | 729 | 0.100 |
Why?
|
| Psychiatric Status Rating Scales | 8 | 2005 | 6031 | 0.100 |
Why?
|
| Seasons | 1 | 1997 | 1523 | 0.100 |
Why?
|
| Temporal Lobe | 2 | 1996 | 1728 | 0.090 |
Why?
|
| Cerebrovascular Circulation | 2 | 1997 | 2736 | 0.080 |
Why?
|
| Frontal Lobe | 1 | 1996 | 1428 | 0.080 |
Why?
|
| Arousal | 2 | 1992 | 1183 | 0.080 |
Why?
|
| Community Mental Health Centers | 1 | 1987 | 93 | 0.070 |
Why?
|
| Mental Disorders | 3 | 1996 | 6879 | 0.060 |
Why?
|
| Anti-Anxiety Agents | 1 | 2008 | 405 | 0.060 |
Why?
|
| Electroconvulsive Therapy | 3 | 2003 | 504 | 0.050 |
Why?
|
| Personality Assessment | 4 | 1996 | 646 | 0.040 |
Why?
|
| Brain | 4 | 1996 | 27476 | 0.040 |
Why?
|
| Longitudinal Studies | 8 | 2008 | 14795 | 0.040 |
Why?
|
| Observer Variation | 1 | 2005 | 2623 | 0.040 |
Why?
|
| Norepinephrine | 2 | 2008 | 900 | 0.040 |
Why?
|
| Guideline Adherence | 2 | 2005 | 2240 | 0.040 |
Why?
|
| Aging | 2 | 1996 | 8765 | 0.040 |
Why?
|
| Electroencephalography | 2 | 1992 | 6318 | 0.030 |
Why?
|
| Regional Blood Flow | 2 | 1996 | 1502 | 0.030 |
Why?
|
| Psychotherapy | 4 | 1994 | 1654 | 0.030 |
Why?
|
| Affect | 1 | 2003 | 1500 | 0.030 |
Why?
|
| Homovanillic Acid | 1 | 1993 | 75 | 0.030 |
Why?
|
| Comorbidity | 8 | 2008 | 10591 | 0.030 |
Why?
|
| Referral and Consultation | 1 | 1987 | 3626 | 0.030 |
Why?
|
| Massachusetts | 2 | 2005 | 8888 | 0.030 |
Why?
|
| Memory | 1 | 2003 | 2210 | 0.030 |
Why?
|
| AIDS Dementia Complex | 1 | 1994 | 155 | 0.030 |
Why?
|
| Transcranial Magnetic Stimulation | 1 | 2003 | 1489 | 0.030 |
Why?
|
| Paroxetine | 1 | 1993 | 181 | 0.030 |
Why?
|
| Fatigue Syndrome, Chronic | 1 | 1994 | 217 | 0.030 |
Why?
|
| Psychiatry | 2 | 1987 | 1716 | 0.020 |
Why?
|
| Male | 19 | 2008 | 365249 | 0.020 |
Why?
|
| Female | 23 | 2008 | 397464 | 0.020 |
Why?
|
| Bipolar Disorder | 2 | 1992 | 5131 | 0.020 |
Why?
|
| Technetium Tc 99m Exametazime | 3 | 1996 | 61 | 0.020 |
Why?
|
| Adult | 16 | 2005 | 223818 | 0.020 |
Why?
|
| Substance-Related Disorders | 3 | 1998 | 4429 | 0.020 |
Why?
|
| Antidepressive Agents | 2 | 1997 | 2914 | 0.020 |
Why?
|
| Employment | 1 | 1997 | 1114 | 0.020 |
Why?
|
| Organotechnetium Compounds | 3 | 1996 | 133 | 0.020 |
Why?
|
| Reproducibility of Results | 3 | 2005 | 20244 | 0.020 |
Why?
|
| Fluoxetine | 1 | 1993 | 735 | 0.020 |
Why?
|
| Interpersonal Relations | 1 | 1997 | 1438 | 0.020 |
Why?
|
| Follow-Up Studies | 5 | 2005 | 39394 | 0.020 |
Why?
|
| Middle Aged | 16 | 2008 | 223740 | 0.020 |
Why?
|
| Humans | 27 | 2008 | 768887 | 0.020 |
Why?
|
| Oximes | 3 | 1996 | 303 | 0.020 |
Why?
|
| Obsessive-Compulsive Disorder | 2 | 1998 | 1510 | 0.020 |
Why?
|
| Patient Care Team | 1 | 1979 | 2527 | 0.020 |
Why?
|
| Suicide, Attempted | 1 | 1997 | 1409 | 0.020 |
Why?
|
| Age Distribution | 2 | 2008 | 2875 | 0.020 |
Why?
|
| Dominance, Cerebral | 1 | 1989 | 624 | 0.020 |
Why?
|
| Aged | 11 | 2008 | 171790 | 0.020 |
Why?
|
| Antipsychotic Agents | 2 | 1993 | 3081 | 0.020 |
Why?
|
| Personality Inventory | 3 | 1994 | 1018 | 0.020 |
Why?
|
| Monoamine Oxidase | 1 | 1986 | 180 | 0.020 |
Why?
|
| Evoked Potentials, Auditory | 1 | 1989 | 533 | 0.020 |
Why?
|
| Photic Stimulation | 1 | 1992 | 2003 | 0.020 |
Why?
|
| Depressive Disorder, Major | 1 | 2003 | 4819 | 0.020 |
Why?
|
| Brain Mapping | 2 | 1992 | 6740 | 0.020 |
Why?
|
| Health Status | 1 | 1997 | 4095 | 0.010 |
Why?
|
| Hydrocortisone | 2 | 1993 | 1842 | 0.010 |
Why?
|
| Time Factors | 1 | 2005 | 40266 | 0.010 |
Why?
|
| Prospective Studies | 7 | 2008 | 54950 | 0.010 |
Why?
|
| Pilot Projects | 2 | 1993 | 8742 | 0.010 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 1989 | 1495 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 1993 | 8559 | 0.010 |
Why?
|
| Visual Cortex | 1 | 1989 | 1112 | 0.010 |
Why?
|
| Therapeutic Community | 1 | 1979 | 19 | 0.010 |
Why?
|
| Treatment Outcome | 5 | 2003 | 65485 | 0.010 |
Why?
|
| Imipramine | 1 | 1979 | 98 | 0.010 |
Why?
|
| Age of Onset | 2 | 1998 | 3346 | 0.010 |
Why?
|
| Psychotropic Drugs | 2 | 1994 | 883 | 0.010 |
Why?
|
| Dexamethasone | 1 | 1986 | 1965 | 0.010 |
Why?
|
| Adolescent | 3 | 1997 | 89247 | 0.010 |
Why?
|
| Diagnosis, Differential | 3 | 1996 | 13020 | 0.010 |
Why?
|
| Cerebral Cortex | 1 | 1992 | 5834 | 0.010 |
Why?
|
| Missouri | 1 | 1995 | 113 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2003 | 4862 | 0.010 |
Why?
|
| Blood Platelets | 1 | 1986 | 2479 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 1992 | 59738 | 0.010 |
Why?
|
| Hospitals, Teaching | 1 | 1979 | 1157 | 0.010 |
Why?
|
| Patient Care Planning | 1 | 1979 | 904 | 0.010 |
Why?
|
| Interprofessional Relations | 1 | 1979 | 997 | 0.010 |
Why?
|
| Social Adjustment | 1 | 1996 | 636 | 0.010 |
Why?
|
| Vanilmandelic Acid | 1 | 1992 | 17 | 0.010 |
Why?
|
| Normetanephrine | 1 | 1992 | 25 | 0.010 |
Why?
|
| Methoxyhydroxyphenylglycol | 1 | 1992 | 93 | 0.010 |
Why?
|
| Attitude of Health Personnel | 1 | 1987 | 3925 | 0.010 |
Why?
|
| Sex Distribution | 1 | 1998 | 2280 | 0.010 |
Why?
|
| New England | 1 | 1995 | 1058 | 0.010 |
Why?
|
| Remission Induction | 1 | 1998 | 2411 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 1998 | 3438 | 0.010 |
Why?
|
| Prolactin | 1 | 1993 | 627 | 0.010 |
Why?
|
| Organ Specificity | 1 | 1996 | 1970 | 0.010 |
Why?
|
| Life Change Events | 1 | 1996 | 962 | 0.010 |
Why?
|
| Neuropsychological Tests | 1 | 2003 | 7148 | 0.010 |
Why?
|
| Social Environment | 1 | 1994 | 1016 | 0.010 |
Why?
|
| Probability | 1 | 1994 | 2483 | 0.000 |
Why?
|
| Depression | 2 | 1998 | 8240 | 0.000 |
Why?
|
| Terminology as Topic | 1 | 1995 | 1541 | 0.000 |
Why?
|
| Alcoholism | 1 | 1998 | 1981 | 0.000 |
Why?
|
| Clinical Enzyme Tests | 1 | 1986 | 114 | 0.000 |
Why?
|
| Physician-Patient Relations | 1 | 1979 | 3269 | 0.000 |
Why?
|
| Practice Guidelines as Topic | 1 | 2003 | 7460 | 0.000 |
Why?
|
| Decision Making | 1 | 1979 | 3952 | 0.000 |
Why?
|
| Quality of Life | 2 | 1998 | 13510 | 0.000 |
Why?
|
| Chronic Disease | 1 | 1979 | 9384 | 0.000 |
Why?
|
| Psychometrics | 1 | 1994 | 3066 | 0.000 |
Why?
|
| Psychotic Disorders | 1 | 1979 | 3279 | 0.000 |
Why?
|
| Risk Assessment | 1 | 2003 | 24330 | 0.000 |
Why?
|
| Survival Analysis | 1 | 1994 | 10115 | 0.000 |
Why?
|
| Schizophrenia | 1 | 1979 | 6987 | 0.000 |
Why?
|
| Sex Factors | 1 | 1994 | 10641 | 0.000 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 1998 | 4642 | 0.000 |
Why?
|
| Risk Factors | 2 | 1998 | 74971 | 0.000 |
Why?
|
| United States | 1 | 2008 | 73180 | 0.000 |
Why?
|
| Double-Blind Method | 1 | 1993 | 12469 | 0.000 |
Why?
|
| Phenothiazines | 1 | 1979 | 60 | 0.000 |
Why?
|
| Internship and Residency | 1 | 1979 | 5956 | 0.000 |
Why?
|
| Desipramine | 1 | 1979 | 183 | 0.000 |
Why?
|
| Severity of Illness Index | 1 | 1994 | 15955 | 0.000 |
Why?
|
| Cohort Studies | 1 | 1996 | 41800 | 0.000 |
Why?
|
| Drug Therapy, Combination | 1 | 1979 | 6320 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 1995 | 81892 | 0.000 |
Why?
|
| Prognosis | 1 | 1986 | 30044 | 0.000 |
Why?
|